Illkirch Graffenstaden, France

Céline Simon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Trophos. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Céline Simon. Retrieved from https://idiyas.com/inventor/céline-simon-4yy04qtu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Céline Simon: Innovator in Neuroprotective Chemical Compounds

Introduction

Céline Simon is a notable inventor based in Illkirch Graffenstaden, France. He has made significant contributions to the field of pharmacy, particularly in the treatment of neurodegenerative diseases. His innovative work has led to the development of novel chemical compounds that demonstrate neuroprotective activity.

Latest Patents

Céline Simon holds 1 patent for his invention titled "Chemical compounds and the uses thereof as a medicine." This invention focuses on a family of chemical compounds that have shown promise in treating neurodegenerative diseases. The patent details the synthesis methods of these novel compounds, as well as their potential applications as medicaments.

Career Highlights

Throughout his career, Céline Simon has been dedicated to advancing pharmaceutical research. His work has not only contributed to the understanding of neurodegenerative diseases but has also paved the way for new treatment options. His innovative approach to chemical compounds has garnered attention in the scientific community.

Collaborations

Céline Simon has collaborated with esteemed colleagues, including Corinne Chaimbault and Cyrille Drouot. These partnerships have enhanced the research and development of his patented compounds, fostering a collaborative environment for innovation.

Conclusion

Céline Simon's contributions to the field of pharmacy through his innovative chemical compounds highlight the importance of research in treating neurodegenerative diseases. His work exemplifies the potential of scientific innovation to improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…